Table 5 summarizes key therapeutic candidates under clinical evaluation or recently approved, highlighting their mechanism of action, clinical stage, and therapeutic targets
In support of this, numerous epidemiological studies including European paradox study (Bellizzi et al., 1994), WHO/MONICA study (Gey and Puska, 1989), NHS study (Stampfer et al., 1993), and Harvard HPSF (Rimm et al., 1993) have shown that antioxidant was negatively associated with many NCDs including cardiovascular diseases
Enteric-coated capsules designed to protect the contents from stomach acid
Muscle Aches and Joint Pain: By downregulating the production of pro-inflammatory cytokines like IL-6 and TNF-alpha, glutathione helps mitigate the systemic inflammation that drives chronic musculoskeletal pain
Epithalon should be kept in a cool, dry place and protected from light and moisture